Professor calls for caution on new screening technology

There should be a moratorium on new screening technology for breast cancer unless it is part of a clinical study, according to an Australian epidemiologist.

Professor Alexandra Barrett from the University of Sydney school of public health says research needs to show the benefits outweigh the harms before new technology is rolled out in routine practice.

For example, 3D tomosynthesis increases